Last update:

Oncology news

One overlooked detail in cancer genomes is rewriting which mutations really matter

It's a fundamental principle of science: Correlation does not equal causation. Every cancer cell has genetic mutations, but not all of those mutations necessarily drive the cancer.

Direct-to-proteasome strategy degrades two cancer proteins and may curb drug resistance

A preclinical study has developed a strategy that enables the forced elimination of proteins that help tumors survive chemotherapy. This finding opens a new avenue to tackle resistance to cancer treatments, one of the major ...

HRT patches to treat prostate cancer—here's how it works

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst side effects—according to a large UK trial published in the New England Journal of Medicine. The ...

What to know about mesothelioma in younger patients

Mesothelioma, a rare cancer that usually starts in the lining around the lungs, has long been thought of as a condition that affects older men—especially those who may have been exposed to asbestos while working in manufacturing ...

Scientists target key protein duo driving colon, liver cancer

Cedars-Sinai Health Sciences University investigators have identified a drug-like compound that prevents two proteins from working together to promote the growth of colorectal and liver cancer. Findings from the preclinical ...

How pancreatic tumors thwart an iron-driven demise

Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be harnessed for cancer therapy. Given that more than 95% of pancreatic ductal adenocarcinomas (PDACs) harbor ...